has been consistently identified in the lungs of patients with chronic obstructive pulmonary disease (COPD). However, its role in the development of the disease remains undefined. Mice that specifically express human MMP-9 in their macrophages were generated, and morphometric, biochemical, and histological analyses were conducted on the transgenic and littermate control mice over 1 yr to determine the effect of macrophage MMP-9 expression on emphysema formation and lung matrix content. Lung morphometry was normal in transgenic mice at 2 mo of age (mean linear intercept ϭ 50 Ϯ 3 littermate mice vs. 51 Ϯ 2 transgenic mice). However, after 12 mo of age, the MMP-9 transgenic mice developed significant air space enlargement (mean linear intercept ϭ 53 Ϯ 3 littermate mice vs. 61 Ϯ 2 MMP-9 transgenic mice; P Ͻ 0.04). Lung hydroxyproline content was not significantly different between wild-type and transgenic mice, but MMP-9 did significantly decrease alveolar wall elastin at 1 yr of age (4.9 Ϯ 0.3% area of alveolar wall in the littermate mice vs. 3.3 Ϯ 0.3% area of alveolar wall in the MMP-9 mice; P Ͻ 0.004). Thus these results establish a central role for MMP-9 in the pathogenesis of this disease by demonstrating that expression of this protease in macrophages can alter the extracellular matrix and induce progressive air space enlargement in mice.protease; extracellular matrix; degradation; macrophage SEVERAL STUDIES HAVE IMPLICATED matrix metalloproteinase (MMP)-9 in the pathogenesis of emphysema. Increased MMP-9 levels were detected in emphysema lung samples (36), and enhanced expression of this protease was noted in alveolar macrophages from chronic obstructive pulmonary disease (COPD) patients (11,43). Similarly, elevated MMP-9 expression and activity were identified in animal models of the disease (58, 68) and were thought to play a role in the destructive process. While these studies associate MMP-9 activity with emphysema, they do not establish that MMP-9 is directly capable of generating structural changes in this disease. Indeed, MMP-9 could be functioning primarily to mediate postinjury repair response in the lungs of COPD patients (29,30). Alveolar macrophages are a major site of production of matrix-degrading enzymes in the lung (11), and these cells exert a key role on the alveolar destruction that occurs in this disease (65,66). Macrophages secrete several proteases that have been implicated in emphysema formation, including the elastolytic cysteine proteinases (cathepsin L and cathepsin S) and several MMPs (MMP-1, -9, and -12; Ref. 49). MMP-9, however, is the protease that has been most consistently identified from the alveolar macrophages of COPD patients (32, 44). Macrophages from COPD patients have increased MMP-9 expression (12) and release greater amounts of MMP-9 upon stimulation with cigarette smoke compared with macrophages from smoking and nonsmoking control subjects (43). These findings are relevant, as MMP-9 is capable of degrading key components of the extracellular matrix (24). Thus its exp...